Returned medicines in community pharmacies of Barcelona, Spain

Pharmacy World and Science

Volumn 30, Issue 3, 2008, Pages 272-277

  Coma, Anna ^a   Modamio, Pilar ^a   Lastra, Cecilia F ^a   Bouvy, Marcel L ^b   Mariño, Eduardo L ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b SIR Institute for Pharmacy Practice and Policy   (Netherlands)

Author keywords

Community pharmacy; Drug expenditure; Medicine waste; Returned medicine; Spain; Unused drug

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIPARASITIC AGENT; CARDIOVASCULAR AGENT; DERMATOLOGICAL AGENT; IMMUNOMODULATING AGENT; RESPIRATORY TRACT AGENT; SEX HORMONE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG COST; DRUG USE; ECONOMIC ASPECT; EXPIRATION DATE; FEMALE; HEALTH CARE SYSTEM; HUMAN; MALE; PHARMACEUTICAL CARE; PRESCRIPTION; QUESTIONNAIRE; SPAIN;

ADULT; DATA COLLECTION; DRUG COSTS; FEMALE; HUMANS; MALE; NATIONAL HEALTH PROGRAMS; PHARMACIES; QUESTIONNAIRES; SPAIN;

EID: 42249106059     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-007-9177-0     Document Type: Article

References (21)

1. Observatorio SNS. Informe anual del Sistema Nacional de Salud 2003. Madrid: Ministerio de Sanidad y Consumo, 2004. http://www.msc.es/organizacion/ sns/informeAnualSNS/home.htm (last accessed 24 October 2006).
2. Simó-Miñana J, Gervas-Camacho J, Seguí-Díaz M, de Pablo-González R, Domínguez-Velázquez J. Spanish health care expenditure in comparison with developed Europe, 1985-2001. The Spanish Primary Care, the European Cinderella. Aten Primaria. 2004;34(9):472-81.
3. Marchiset N, Gerbaud L, Sauvant M-P, Jaffeux P, Mnhes G, Leblanc N, et al. Description des Médicaments Non Utilisés (MNU) collectés dans les pharmacies du Puy de Dome. Rev d'Epidémiol Sante Publique. 2001;49(6):551-8.
4. Ballu O. Statut des médicaments non utilisés (MNU). France: École Nationale de la Santé Publique (ENSP), Rennes; 2003. (ISBN 002B30A11).
5. Sistema Integrado de Gestión y Recogida de Envases (SIGRE). http://www.sigre.es/inicio.asp (last accessed 24 October 2006).
6. Braybrook S, John DN, Leong K. A survey of why medicines are returned to pharmacies. Pharm J. 1999;263:7063.
7. Grant P. Return of waste medicines to a community pharmacy. Prescriber 2001;12(4):29-38.
8. Langley C, Marriott J, Mackridge A, Daniszewski R. An analysis of returned medicines in primary care. Pharm World Sci. 2005;27(4):296-9.
9. Ekedahl ABE. Reasons why medicines are returned to Swedish pharmacies unused. Pharm World Sci. 2006;28:352-8.
10. WHO. ATC/DDD Index. http://www.whocc.no/atcddd (last accessed 15 September 2006).
11. Cameron S. Study by Alberta pharmacists indicates drug wastage a "mammoth" problem. Can Med Assoc J. 1996;155(11):1596-8.
12. Bronder E, Klimpel A. Unused drugs returned to the pharmacy-new data. Int J Clin Pharmacol Ther. 2001;39(11):480-3.
13. Isacson D, Olofsson C. Drugs up in smoke: a study of caseated drugs in Sweden. Pharm World Sci. 1999;21(2):96-9.
14. Ekedahl A, Wergeman L, Rydberg T. Unused drugs in Sweden measured by returns to pharmacies. J Soc-Adm-Pharm. 2003;20(1):26-31.
15. Anonym. Indicadores de la prestación farmacéutica del SNS a través de receta. Año 2003-Medidas de Farmacovigilancia. Inf Ter Sist Nac Salud. 2004;28(5):128.
16. Bouvy M, Coma A, Mariño EL, Modamio P. European survey about unused drugs. Pharm World Sci. 2005;27:A79.
17. Organization for Economic Co-operation and Development (OCDE). OCDE Health Data 2004. http://www.oecd.org/dataoecd/60/25/31819753.pdf (last accessed 15 September 2006).
18. Cromarty E, Downie G. Drug wastage-what is acceptable? Pharm J. 2001;267(7167):424.
19. Longmore RB, Sunderland VB, Sansom LN. Analysis of a "Medidump" campaign in Australia. Int J Pharm Pract. 1995;3:186-91.
20. Garey KW, Johle ML, Behrman K, Neuhauser MM. Economic consequences of unused medications in Houston, Texas. Ann Pharmacother. 2004;38:1165-8.
21. Smith CA. Managing pharmaceutical waste: what pharmacists should know. J Pharm Soc Wisc. 2002; Nov/Dec:17-22.